Zhejiang Ausun Pharmaceutical Co., Ltd. Class ASSE: 603229

Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Entecavir Tablets

· Issued by Zhejiang Ausun Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Wholly-owned Subsidiary Obtaining Drug Registration Certificate for Entecavir Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment